As a result of the settlement, the company was required to implement enhanced compliance measures and was subjected to ongoing monitoring. In 2018, Inform Diagnostics agreed to pay $63.5 million to resolve the lawsuit. Additionally, the lawsuit also alleged that the company was overcharging patients for certain tests. According to the lawsuit, the company was allegedly billing Medicare for expensive diagnostic tests and procedures that were not medically necessary. In 2015, whistle-blower Chris Riedel filed a lawsuit against Inform Diagnostics (formerly known as Miraca Life Sciences Inc.), alleging that the company was falsely billing Medicare for diagnostic tests. To understand the impact of the Inform Diagnostics lawsuit, it’s essential to first understand the backstory. In this article, we’ll explore the impact of the Inform Diagnostics lawsuit and its implications for patient care. The lawsuit, which involved allegations of false billing and overcharging for diagnostic tests, had significant repercussions on patient care and testing accuracy. One recent case that made headlines was the Inform Diagnostics lawsuit. In recent years, the healthcare industry has been hit by countless lawsuits, with a significant number involving diagnostic laboratories. The Impact of the Inform Diagnostics Lawsuit on Patient Care and Testing Accuracy Diagnostics, impact, inform, lawsuit, tests
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |